Scintigraphy with In-111 labeled lymphokine-activated killer cells of malignant brain tumor.


This study was undertaken to assess the in vivo distribution and migration of lymphokine-activated killer (LAK) cells to the target malignant foci in four patients with advanced malignant brain tumor. All four patients had failed to respond to prior adoptive immunotherapy. After the intravenous administration of radiolabeled LAK cells, most of the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.